Xenetic Biosciences, Inc.
XBIO· Nasdaq
XBIOXenetic Biosciences, Inc.
Filed Aug 10, 2018 · 10-Q · 41 days after period end · 0001683168-18-002256
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Net Income | -$2.03M | -$2.92M | -$47.77M | -$1.13M |
| EPS Diluted | -$2.78 | -$0.34 | -$6.12 | -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 10, 2018 · 41 d after period end
